If you're having trouble viewing this email, you may see it online.

Share this:
http://www.cttc.co/content/about http://www.cttc.co/content/inventors http://www.cttc.co/industry http://www.cttc.co/content/new-ventures
Vanderbilt launches automated system for MTAs
MTAShare, Vanderbilt's new automated system for processing and managing Material Transfer Agreements (MTAs), is now live for the transfer of materials from Vanderbilt labs to academic and not-for-profit institutions. The system is fast and easy to use and utilizes widely accepted, standardized agreements to avoid the need for protracted negotiations.
Developed by Paul Harris and colleagues in the Office of Biomedical Informatics, and powered by REDCap, the system was presented at a recent national professional conference of 2,000 academic licensing professionals and was met with great enthusiasm from other academic institutions.  
If you need assistance sending an MTA to a university or not-for-profit, please contact your CTTC licensing officer.

Life Science TN to host a Patent Law Update
Wednesday, March 12, from 11:30 a.m. - 1 p.m., Life Science Tennessee will host a presentation on important patent law updates relevant to the life sciences industry.  Paul Ney, Nate Bailey and Jim Cartiglia, intellectual property attorneys at Waddey Patterson, will discuss the pending legislation relating to "patent troll” litigation, recently implemented inter parties review procedures, and recent Supreme Court cases involving patent law. Lunch will be provided. RSVP to info@lifesciencetn.org
Weekly interactions: 
CTTC staff members work diligently to manage all disclosures and requests in a timely manner. Below is a sampling of the activity that has taken place in our office over the past few weeks:
Executed an exclusive license with a startup company for the polymeric nanoparticles developed by Eva Harth in the Department of Chemistry.
Hosted a lunch and learn event for Vanderbilt researchers to learn about KeraFAST's Investigator's Annexe Program that markets and distributes university research tools.
Executed an exclusive license agreement with a startup company for the use of My Cancer Genome developed by William Pao and Mia Levy of Vanderbilt-Ingram Cancer Center.
Attended the annual Association of University Technology Managers conference and met with companies to market Vanderbilt's Small MoleculeTherapeutics and Companion Diagnostics Pipeline and Research Tools Catalog.
Discussed opportunities for commercialization of insect repellent technologies, developed by Larry Zwiebel in the Department of Biological Sciences, with a potential partner and with a potential end-user company.
Participated in a teleconference with a pharmaceutical company regarding phospholipase D (PLD) inhibitor compounds developed by Alex Brown and Craig Lindsley in the Center for Neuroscience Drug Discovery.
Discussed the development and licensing of a diagnostic test to measure risk of pulmonary hypertension in cattle with a company that specializes in animal health testing.  The technology was developed by John Newman in the Division of Allergy, Pulmonary and Critical Care Medicine and colleagues. 
Entered a confidentiality agreement with a small biotech company interested in exploring commercialization potential of a soluble protein from a probiotic bacteria that shows protective effects in mouse model of colitis, developed by Fang Yan in Pediatric Gastroenterology and Brent Polk, Professor and Chairman of Pediatrics, Saban Research Institute Children's Hospital Los Angeles.
Entered a confidentiality agreement with a large pharmaceutical research foundation to explore a new assay for alpha cell proliferation developed by Al Powers, Director of the Vanderbilt Diabetes Center and Erika Danielle Dean in the Division of Diabetes, Endocrinology, and Metabolism.
Met with a local investor and regional entrepreneur interested in investing in commercialization of therapeutic peptides and proteins developed by Jack Hawiger in the Division of Allergy, Pulmonary and Critical Care Medicine.
Participated in a webinar that discussed effective strategies for managing milestones for university startups.
Hosted a "how-to" course for developing a business strategy to students participating in the 2014 Tech Venture Challenge.
FY 2014 Statistics
Agreements administered by CTTC 
Material Transfer
IP-related activities 
Invention Disclosures 
U.S. Patents Issued
*includes end-user license agreements
Research and technology production pipeline catalogs now available
Research Tools Catalog
Small Molecule Therapeutics & Companion Diagnostics Pipeline
CTTC staff recognized at national conference
Alan Bentley, assistant vice chancellor for technology transfer and intellectual property protection, and Masood Machingal, licensing analyst, were among just a handful of technology licensing professionals recognized at the 2014 Association of University Technology Managers (AUTM) annual conference. Bentley received a Volunteer Service Award for his commitment to developing sound metrics and quality survey tools for technology transfer professionals. Machingal was one of just five individuals awarded a Howard Bremer Scholarship to attend the conference. The scholarship honors Bremer, a pioneer in the technology transfer profession and former AUTM president, and is awarded to new  professionals who bring creativity and innovation to the industry.
Driving innovation forward: It's what we do
KIYATEC, a South Carolina-based small business, is finalizing plans with Vanderbilt to commercialize novel, miniaturized peristaltic pump technology developed in the laboratories of Prof. John Wikswo. In collaboration with the Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE), the company has successfully developed prototype pumps and associated systems which were recently featured in meetings on Capitol Hill between top NIH leadership and members of congress.
“We are very excited about the potential impact of this micro-pump technology, both through external sales and internal use for our 3D cell culture systems.” said CEO Matt Gevaert.  “Together with Vanderbilt, we believe this technology can translate successfully to improve fluidic based products in multiple markets.” 
The pumps  can be utilized either as a stand-along device or incorporated into microfluidic subsystems for research instruments or miniaturized point-of-care instruments, Lab on a Chip devices, and disposable fluid delivery cartridges. A key advantage of the pump is that it can deliver flow rates that are roughly 1/10th the cost of stand-alone commercial syringe and peristaltic pumps. Read more about it here.
1207 17th Ave South | Suite 105 | Nashville, TN 37212
p 615.343.2430 | f 615.343.4419 | cttc@vanderbilt.edu | www.vanderbilt.edu/cttc
http://www.linkedin.com/groups/Vanderbilt-Center-Technology-Transfer-Commercialization-4139396?gid=4139396&trk=hb_side_g http://www.youtube.com/vanderbiltcttc http://twitter.com/#!/VanderbiltCTTC https://www.facebook.com/VanderbiltCTTC?v=app_197602066931325&app_data=%26wlbb%3D1%26fanmode%3Dnon http://www.vanderbilt.edu/cttc/

This email was sent to kara.bandy@vanderbilt.edu. To ensure that you continue receiving our emails,
please add us to your address book or safe list.
manage your preferences | opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.

powered by emma